• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受抗逆转录病毒治疗的HIV感染儿童的异烟肼预防性治疗:一项试点研究。

Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study.

作者信息

Gray D M, Workman L J, Lombard C J, Jennings T, Innes S, Grobbelaar C J, Cotton M F, Zar H J

机构信息

Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.

Biostatistics Unit, Medical Research Council, Cape Town, South Africa.

出版信息

Int J Tuberc Lung Dis. 2014 Mar;18(3):322-7. doi: 10.5588/ijtld.13.0354.

DOI:10.5588/ijtld.13.0354
PMID:24670570
Abstract

SETTING

Tuberculosis (TB) is a common cause of mortality and morbidity in children infected with the human immunodeficiency virus (HIV). Data on isoniazid preventive therapy (IPT) efficacy in HIV-infected children receiving antiretroviral therapy (ART) are inconclusive.

OBJECTIVE

To assess the efficacy, tolerability and safety of isoniazid (INH) in HIV-infected children on ART.

DESIGN

A pilot randomised controlled study of INH was undertaken in HIV-infected children on ART. The primary outcome measure was TB disease or death.

RESULTS

A total of 167 children were randomised to receive INH (n = 85) or placebo (n = 82), and followed for a median of 34 months (interquartile range [IQR] 24-52). The median age was 35 months (IQR 15-65). There was one death in a child on INH and none in the placebo group. Eleven (6.6%) cases of TB occurred, 4 (5%) in the INH and 7 (9%) in the placebo group. Among the TB cases, 5 were culture confirmed-2 in the INH group and 3 in the placebo group, all susceptible to INH. Severe adverse events occurred rarely (n = 6; 2%).

CONCLUSION

IPT is safe and well tolerated in HIV-infected children on concomitant ART. This study supports the need for a larger study to assess efficacy in HIV-infected children living in TB-endemic areas.

摘要

背景

结核病是感染人类免疫缺陷病毒(HIV)儿童死亡和发病的常见原因。关于接受抗逆转录病毒治疗(ART)的HIV感染儿童中异烟肼预防性治疗(IPT)疗效的数据尚无定论。

目的

评估异烟肼(INH)对接受ART的HIV感染儿童的疗效、耐受性和安全性。

设计

对接受ART的HIV感染儿童进行了一项关于INH的试点随机对照研究。主要结局指标为结核病或死亡。

结果

共有167名儿童被随机分组,分别接受INH(n = 85)或安慰剂(n = 82),并随访了34个月(四分位间距[IQR]24 - 52)。中位年龄为35个月(IQR 15 - 65)。接受INH治疗的儿童中有1例死亡,安慰剂组无死亡。发生了11例(6.6%)结核病病例,INH组4例(5%),安慰剂组7例(9%)。在结核病病例中,5例经培养确诊——INH组2例,安慰剂组3例,均对INH敏感。严重不良事件很少发生(n = 6;2%)。

结论

在接受ART的HIV感染儿童中,IPT安全且耐受性良好。本研究支持需要进行更大规模的研究,以评估结核病流行地区HIV感染儿童的疗效。

相似文献

1
Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study.接受抗逆转录病毒治疗的HIV感染儿童的异烟肼预防性治疗:一项试点研究。
Int J Tuberc Lung Dis. 2014 Mar;18(3):322-7. doi: 10.5588/ijtld.13.0354.
2
Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.结核病预防性治疗对感染艾滋病毒儿童的结核病及死亡率的影响。
Cochrane Database Syst Rev. 2009 Jan 21(1):CD006418. doi: 10.1002/14651858.CD006418.pub2.
3
The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.在高结核发病率环境中,异烟肼预防治疗和抗逆转录病毒治疗对感染 HIV 的儿童结核病的影响。
Thorax. 2011 Jun;66(6):496-501. doi: 10.1136/thx.2010.156752. Epub 2011 Apr 2.
4
Isoniazid for preventing tuberculosis in HIV-infected children.异烟肼用于预防感染艾滋病毒儿童的结核病。
Cochrane Database Syst Rev. 2017 Aug 29;8(8):CD006418. doi: 10.1002/14651858.CD006418.pub3.
5
Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.异烟肼预防性治疗在南非晚期HIV疾病成人患者中的随机对照试验。
Int J Tuberc Lung Dis. 2007 Oct;11(10):1114-20.
6
Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients.异烟肼预防治疗与泰国 HIV 感染患者的 4 年肺结核发病风险。
Int J Tuberc Lung Dis. 2012;16(3):336-41. doi: 10.5588/ijtld.11.0402. Epub 2012 Jan 5.
7
Isoniazid preventive therapy use among patients on antiretroviral therapy: a missed opportunity.接受抗逆转录病毒治疗的患者中异烟肼预防性治疗的使用:一个被错失的机会。
Int J Tuberc Lung Dis. 2014 Mar;18(3):312-4. doi: 10.5588/ijtld.13.0505.
8
Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.柬埔寨一家艾滋病诊所中异烟肼预防性治疗的实施情况:与抗逆转录病毒疗法联合使用时停药率较高。
Trop Med Int Health. 2015 Dec;20(12):1823-31. doi: 10.1111/tmi.12609. Epub 2015 Oct 19.
9
Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana.博茨瓦纳感染 HIV 的成年人接受异烟肼预防治疗后的抗结核治疗结局。
Int J Tuberc Lung Dis. 2013 Feb;17(2):178-85. doi: 10.5588/ijtld.12.0314.
10
Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.在一项异烟肼预防研究中对暴露于HIV的婴儿进行源病例识别及结核病诊断。
Int J Tuberc Lung Dis. 2016 Aug;20(8):1060-4. doi: 10.5588/ijtld.15.0602.

引用本文的文献

1
Clinical practice guideline for the evaluation, treatment, and follow-up of children in contact with patients with pulmonary tuberculosis in Colombia.哥伦比亚接触肺结核患者儿童的评估、治疗及随访临床实践指南
Colomb Med (Cali). 2025 Mar 30;56(1):e6005918. doi: 10.25100/cm.v56i1.5918. eCollection 2025 Jan-Mar.
2
Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials.不同治疗方案治疗潜伏性结核感染患者的疗效与安全性:一项随机对照试验的系统评价和网状Meta分析
Arch Public Health. 2023 May 5;81(1):82. doi: 10.1186/s13690-023-01098-z.
3
Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
HIV 感染者的结核病预防治疗:系统评价和网络荟萃分析。
PLoS Med. 2021 Sep 14;18(9):e1003738. doi: 10.1371/journal.pmed.1003738. eCollection 2021 Sep.
4
Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.在坦桑尼亚的一家儿科艾滋病毒诊所成功实施异烟肼预防治疗。
BMC Infect Dis. 2020 Oct 7;20(1):738. doi: 10.1186/s12879-020-05471-z.
5
A Randomized Controlled Trial of Isoniazid to Prevent Mycobacterium tuberculosis Infection in Kenyan Human Immunodeficiency Virus-Exposed Uninfected Infants.随机对照试验:异烟肼预防肯尼亚 HIV 暴露未感染婴儿结核分枝杆菌感染
Clin Infect Dis. 2021 Jul 15;73(2):e337-e344. doi: 10.1093/cid/ciaa827.
6
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.潜伏结核感染治疗指南:美国国家结核病控制协会和美国疾病预防控制中心 2020 年推荐意见。
MMWR Recomm Rep. 2020 Feb 14;69(1):1-11. doi: 10.15585/mmwr.rr6901a1.
7
Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent infection in HIV-exposed uninfected children.婴儿结核病感染预防研究(iTIPS):一项随机试验方案,评估异烟肼预防 HIV 暴露但未感染儿童的感染。
BMJ Open. 2020 Jan 21;10(1):e034308. doi: 10.1136/bmjopen-2019-034308.
8
Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children: A Systematic Review and Meta-Analysis.异烟肼预防 HIV 感染儿童结核病:系统评价和荟萃分析。
Pediatr Infect Dis J. 2018 Aug;37(8):773-780. doi: 10.1097/INF.0000000000001879.
9
Isoniazid for preventing tuberculosis in HIV-infected children.异烟肼用于预防感染艾滋病毒儿童的结核病。
Cochrane Database Syst Rev. 2017 Aug 29;8(8):CD006418. doi: 10.1002/14651858.CD006418.pub3.
10
The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis.艾滋病毒和抗逆转录病毒疗法对儿童结核病风险的影响:一项系统评价和荟萃分析。
Thorax. 2017 Jun;72(6):559-575. doi: 10.1136/thoraxjnl-2016-209421. Epub 2017 Jan 23.